| BOLT YTD Return Table | ||||||||||||||||||||||||||||||
BOLT YTD return is presented with the assumption of reinvestments of any dividends on ex-date. |
| YTD Return Benchmarks |
|
Compare BOLT YTD return (see YTD Return Formula;
YTD Return vs Yield) versus benchmarks: YTD Return on S&P YTD Return on Dow YTD Return on Nasdaq 100 YTD Return on Russell 2000 YTD Return on Gold YTD Return on 10 Year Treasury |
| BOLT Share Performance |
| BOLT YTD Return Chart | |||
Also see: BOLT Average Annual Return | |||
| About Bolt Biotherapeutics Inc |
| Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Co.'s pipeline candidates are built on its expertise in myeloid biology and cancer drug development. Its pipeline includes trastuzumab imbotolimod (formerly BDC-1001), a human epidermal growth factor receptor 2 - targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. Trastuzumab imbotolimod is in Phase 2 clinical. BDC-3042, an agonist antibody targeting Dectin-2, is in a Phase 1 dose-escalation trial. The BOLT YTD return is shown above.
The YTD Return on the BOLT YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis. Thus, researching Year-To-Date Returns is good practice for investors — whether BOLT YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the BOLT YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns. |
| BOLT Current Stock Quote |
 Free BOLT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in YTD Return! | |
|
| YTD Return Peers |
| Bolt Biotherapeutics (BOLT) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:
BPMC YTD Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.
Video: Don't Forget Dividends in YTD Return!